TrialLeukemia & lymphoma2015

Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma.

Ellen J Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.